Copyright Reports & Markets. All rights reserved.

Global Macular Degeneration Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Macular Degeneration Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Lucentis
      • 1.4.3 Eylea
      • 1.4.4 Avastin
      • 1.4.5 Others
    • 1.5 Market by Application
      • 1.5.1 Global Macular Degeneration Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Eye Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Macular Degeneration Treatment Market Size
    • 2.2 Macular Degeneration Treatment Growth Trends by Regions
      • 2.2.1 Macular Degeneration Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Macular Degeneration Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Macular Degeneration Treatment Market Size by Manufacturers
      • 3.1.1 Global Macular Degeneration Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Macular Degeneration Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Macular Degeneration Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Macular Degeneration Treatment Key Players Head office and Area Served
    • 3.3 Key Players Macular Degeneration Treatment Product/Solution/Service
    • 3.4 Date of Enter into Macular Degeneration Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Macular Degeneration Treatment Market Size by Type (2014-2019)
    • 4.2 Global Macular Degeneration Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Macular Degeneration Treatment Market Size (2014-2019)
    • 5.2 Macular Degeneration Treatment Key Players in United States
    • 5.3 United States Macular Degeneration Treatment Market Size by Type
    • 5.4 United States Macular Degeneration Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Macular Degeneration Treatment Market Size (2014-2019)
    • 6.2 Macular Degeneration Treatment Key Players in Europe
    • 6.3 Europe Macular Degeneration Treatment Market Size by Type
    • 6.4 Europe Macular Degeneration Treatment Market Size by Application

    7 China

    • 7.1 China Macular Degeneration Treatment Market Size (2014-2019)
    • 7.2 Macular Degeneration Treatment Key Players in China
    • 7.3 China Macular Degeneration Treatment Market Size by Type
    • 7.4 China Macular Degeneration Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Macular Degeneration Treatment Market Size (2014-2019)
    • 8.2 Macular Degeneration Treatment Key Players in Japan
    • 8.3 Japan Macular Degeneration Treatment Market Size by Type
    • 8.4 Japan Macular Degeneration Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Macular Degeneration Treatment Market Size (2014-2019)
    • 9.2 Macular Degeneration Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Macular Degeneration Treatment Market Size by Type
    • 9.4 Southeast Asia Macular Degeneration Treatment Market Size by Application

    10 India

    • 10.1 India Macular Degeneration Treatment Market Size (2014-2019)
    • 10.2 Macular Degeneration Treatment Key Players in India
    • 10.3 India Macular Degeneration Treatment Market Size by Type
    • 10.4 India Macular Degeneration Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Macular Degeneration Treatment Market Size (2014-2019)
    • 11.2 Macular Degeneration Treatment Key Players in Central & South America
    • 11.3 Central & South America Macular Degeneration Treatment Market Size by Type
    • 11.4 Central & South America Macular Degeneration Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Bausch Health Companies
      • 12.1.1 Bausch Health Companies Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Macular Degeneration Treatment Introduction
      • 12.1.4 Bausch Health Companies Revenue in Macular Degeneration Treatment Business (2014-2019)
      • 12.1.5 Bausch Health Companies Recent Development
    • 12.2 Allergan
      • 12.2.1 Allergan Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Macular Degeneration Treatment Introduction
      • 12.2.4 Allergan Revenue in Macular Degeneration Treatment Business (2014-2019)
      • 12.2.5 Allergan Recent Development
    • 12.3 Novartis
      • 12.3.1 Novartis Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Macular Degeneration Treatment Introduction
      • 12.3.4 Novartis Revenue in Macular Degeneration Treatment Business (2014-2019)
      • 12.3.5 Novartis Recent Development
    • 12.4 Pfizer
      • 12.4.1 Pfizer Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Macular Degeneration Treatment Introduction
      • 12.4.4 Pfizer Revenue in Macular Degeneration Treatment Business (2014-2019)
      • 12.4.5 Pfizer Recent Development
    • 12.5 Bayer
      • 12.5.1 Bayer Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Macular Degeneration Treatment Introduction
      • 12.5.4 Bayer Revenue in Macular Degeneration Treatment Business (2014-2019)
      • 12.5.5 Bayer Recent Development
    • 12.6 Roche
      • 12.6.1 Roche Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Macular Degeneration Treatment Introduction
      • 12.6.4 Roche Revenue in Macular Degeneration Treatment Business (2014-2019)
      • 12.6.5 Roche Recent Development
    • 12.7 Sanofi
      • 12.7.1 Sanofi Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Macular Degeneration Treatment Introduction
      • 12.7.4 Sanofi Revenue in Macular Degeneration Treatment Business (2014-2019)
      • 12.7.5 Sanofi Recent Development
    • 12.8 Santen Pharmaceuticals
      • 12.8.1 Santen Pharmaceuticals Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Macular Degeneration Treatment Introduction
      • 12.8.4 Santen Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2014-2019)
      • 12.8.5 Santen Pharmaceuticals Recent Development
    • 12.9 Regeneron Pharmaceuticals
      • 12.9.1 Regeneron Pharmaceuticals Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Macular Degeneration Treatment Introduction
      • 12.9.4 Regeneron Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2014-2019)
      • 12.9.5 Regeneron Pharmaceuticals Recent Development
    • 12.10 Kanghong Pharma
      • 12.10.1 Kanghong Pharma Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Macular Degeneration Treatment Introduction
      • 12.10.4 Kanghong Pharma Revenue in Macular Degeneration Treatment Business (2014-2019)
      • 12.10.5 Kanghong Pharma Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. Early on there are often no symptoms. Over time, however, some people experience a gradual worsening of vision that may affect one or both eyes. While it does not result in complete blindness, loss of central vision can make it hard to recognize faces, drive, read, or perform other activities of daily life. Visual hallucinations may also occur but these do not represent a mental illness.
      In 2018, the global Macular Degeneration Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Macular Degeneration Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Macular Degeneration Treatment development in United States, Europe and China.

      The key players covered in this study
      Bausch Health Companies
      Allergan
      Novartis
      Pfizer
      Bayer
      Roche
      Sanofi
      Santen Pharmaceuticals
      Regeneron Pharmaceuticals
      Kanghong Pharma

      Market segment by Type, the product can be split into
      Lucentis
      Eylea
      Avastin
      Others

      Market segment by Application, split into
      Hospitals
      Eye Clinics
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Macular Degeneration Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Macular Degeneration Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Macular Degeneration Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now